4.8 Article

Spatial biology analysis reveals B cell follicles in secondary lymphoid structures may regulate anti-tumor responses at initial melanoma diagnosis

Related references

Note: Only part of the references are listed.
Review Immunology

From Antibody Repertoires to Cell-Cell Interactions to Molecular Networks: Bridging Scales in the Germinal Center

Haripriya Vaidehi Narayanan et al.

Summary: Antibody-mediated adaptive immunity must provide long-term protection against rapidly mutating pathogens in a diverse human population. Understanding the multiscale germinal center (GC) reaction, which is responsible for the evolution of high-affinity antigen-specific antibodies, is crucial. This article advocates for a mechanistic understanding of B-cell dynamics at organism, tissue/cellular, and molecular scales, and emphasizes the importance of quantitative multi-scale mathematical models in predicting B-cell and GC reaction dynamics for practical applications such as vaccine design.

FRONTIERS IN IMMUNOLOGY (2022)

Article Oncology

Dissecting the immune landscape of tumor draining lymph nodes in melanoma with high-plex spatially resolved protein detection

Georgia M. Beasley et al.

Summary: In melanoma patients, the infiltration of CD3 cells in the sentinel lymph nodes varies among patients, with higher infiltration of CD11c and CD3 cells in the SLN tumor region associated with longer overall survival. Expression of DC activation markers such as CD86, HLA-DR, and OX40L on CD11c cells within the SLN tumor region correlates with patient survival, with lowest expression in patients with shorter survival and highest in patients with longer survival. Further studies are needed in a larger cohort to validate these findings.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)

Review Oncology

B7-H3: An Attractive Target for Antibody-based Immunotherapy

Filippos Kontos et al.

Summary: B7-H3, as a potential target for antibody-based immunotherapy, is overexpressed in malignant tissues and associated with poor prognosis. Although the receptor for B7-H3 remains unknown, various antibody-based strategies targeting B7-H3-expressing cancer cells have been developed, demonstrating potent antitumor activity in preclinical models. Ongoing clinical trials are evaluating the safety and efficacy of these strategies in patients, with the hope of enhancing the therapeutic efficacy of tumor immunity.

CLINICAL CANCER RESEARCH (2021)

Article Oncology

Characterization of Sentinel Lymph Node Immune Signatures and Implications for Risk Stratification for Adjuvant Therapy in Melanoma

Norma E. Farrow et al.

Summary: The gene expression profiles of sentinel lymph nodes are associated with melanoma recurrence and can potentially identify patients as high or low risk for recurrence regardless of sentinel lymph node status, enhancing patient selection for adjuvant therapy.

ANNALS OF SURGICAL ONCOLOGY (2021)

Review Immunology

B Cells in Patients With Melanoma: Implications for Treatment With Checkpoint Inhibitor Antibodies

Zena N. Willsmore et al.

Summary: The diverse roles of B cells in melanoma, from forming tertiary lymphoid structures to influencing immunotherapy response, suggest they are key players in the complex immune environment of the tumor. Certain B cell phenotypes are associated with positive responses to CPI immunotherapy, while others may be linked to adverse events, highlighting their potential as biomarkers for treatment optimization.

FRONTIERS IN IMMUNOLOGY (2021)

Article Oncology

Heterogeneity in tertiary lymphoid structure B-cells correlates with patient survival in metastatic melanoma

Kevin T. Lynch et al.

Summary: The presence of TLS in cutaneous melanoma metastases is associated with increased intratumoral lymphocyte infiltration and improved overall survival in patients. Different types of TLS have varying effects on patient survival, indicating potential regulatory or antigen-driven immune responses.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Article Cell Biology

Spatiotemporal Analysis of B Cell- and Antibody Secreting Cell-Subsets in Human Melanoma Reveals Metastasis-, Tumor Stage-, and Age-Associated Dynamics

Minyi Chen et al.

Summary: This study provides a comprehensive analysis of major B cell and antibody secreting cell subpopulations in human melanoma, revealing a higher proportion of plasma cell-like cells at distant metastatic sites and a higher proportion of memory-like B cells at locoregional than distant metastatic sites. These findings suggest potential clinical significance and implications for biomarker and therapy studies related to B cells.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Review Biochemistry & Molecular Biology

B7-H3 Immune Checkpoint Protein in Human Cancer

Karine Flem-Karlsen et al.

CURRENT MEDICINAL CHEMISTRY (2020)

Review Biotechnology & Applied Microbiology

Role of Inducible Co-Stimulator (ICOS) in cancer immunotherapy

Florent Amatore et al.

EXPERT OPINION ON BIOLOGICAL THERAPY (2020)

Article Multidisciplinary Sciences

Tertiary lymphoid structures improve immunotherapy and survival in melanoma

Rita Cabrita et al.

NATURE (2020)

Article Multidisciplinary Sciences

B cells and tertiary lymphoid structures promote immunotherapy response

Beth A. Helmink et al.

NATURE (2020)

Review Immunology

Lymph node stromal cells: cartographers of the immune system

Akshay T. Krishnamurty et al.

NATURE IMMUNOLOGY (2020)

Article Immunology

Examining Peripheral and Tumor Cellular Immunome in Patients With Cancer

Eda K. Holl et al.

FRONTIERS IN IMMUNOLOGY (2019)

Article Multidisciplinary Sciences

B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma

Johannes Griss et al.

NATURE COMMUNICATIONS (2019)

Review Oncology

Updates in adjuvant systemic therapy for melanoma

Minyoung Kwak et al.

JOURNAL OF SURGICAL ONCOLOGY (2019)

Review Oncology

Sentinel Lymph Node Biopsy and Completion Lymph Node Dissection for Melanoma

Sabran J. Masoud et al.

CURRENT TREATMENT OPTIONS IN ONCOLOGY (2018)

Article Multidisciplinary Sciences

Tumor-associated B-cells induce tumor heterogeneity and therapy resistance

Rajasekharan Somasundaram et al.

NATURE COMMUNICATIONS (2017)

Review Immunology

B cell regulation in cancer and anti-Xtumor immunity

Anushruti Sarvaria et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2017)

Review Multidisciplinary Sciences

T cell exclusion, immune privilege, and the tumor microenvironment

Johanna A. Joyce et al.

SCIENCE (2015)

Article Multidisciplinary Sciences

Regulatory B cells preferentially accumulate in tumor-draining lymph nodes and promote tumor growth

Sheila N. Ganti et al.

SCIENTIFIC REPORTS (2015)

Article Oncology

Evidence of Th2 polarization of the sentinel lymph node (SLN) in melanoma

Travis E. Grotz et al.

ONCOIMMUNOLOGY (2015)

Article Surgery

Comparison of Sentinel Lymph Node Micrometastatic Tumor Burden Measurements in Melanoma

Michael E. Egger et al.

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2014)

Article Medicine, General & Internal

Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in Melanoma

D. L. Morton et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Review Immunology

T cells and follicular dendritic cells in germinal center B-cell formation and selection

Carola G. Vinuesa et al.

IMMUNOLOGICAL REVIEWS (2010)

Article Medical Laboratory Technology

False-positive cells in sentinel lymph nodes

Jeoffry B. Brennick et al.

SEMINARS IN DIAGNOSTIC PATHOLOGY (2008)

Article Pathology

False-positive rate of the immunoperoxidase stains for MART1/MelanA in lymph nodes

SF Yan et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)